Powder: -20°C for 3 years | In solvent: -80°C for 1 year
Licarbazepine (10,11-hydroxy-10,11 Dihydrocarbamezer) is the pharmacologically active metabolite of oxcarbazepine, a drug indicated for the treatment of partial seizures and bipolar disorders.
パッケージサイズ | 在庫状況 | 単価(税別) | |||
---|---|---|---|---|---|
サンプルについてお問い合わせ | |||||
10 mg | 在庫あり | ¥ 10,000 | |||
25 mg | 在庫あり | ¥ 16,000 | |||
50 mg | 在庫あり | ¥ 22,500 | |||
100 mg | 在庫あり | ¥ 28,000 | |||
200 mg | 在庫あり | ¥ 41,000 |
説明 | Licarbazepine (10,11-hydroxy-10,11 Dihydrocarbamezer) is the pharmacologically active metabolite of oxcarbazepine, a drug indicated for the treatment of partial seizures and bipolar disorders. |
別名 | 10,11-hydroxy-10,11 Dihydrocarbamezer |
分子量 | 254.28 |
分子式 | C15H14N2O2 |
CAS No. | 29331-92-8 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
DMSO: 3mg/ml(11.7mM)
You can also refer to dose conversion for different animals. 詳細
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
Licarbazepine 29331-92-8 Others 10,11-hydroxy-10,11 Dihydrocarbamezer partial Sodium Channel Na channels voltage Inhibitor sodium seizures stabilizing BIA 2-005 gated channel,?blocker,?anticonvulsant,?mood GP47779 epilepsy GP-47779 Na+ channels inhibit 10,11-hydroxy-10,11 Dihydrocarbamezer GP 47779 onset inhibitor